{"id":482327,"title":"Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T18:52:54.144000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/drug-identification-numbers-schedulec.html?wbdisable=true","snippet":"Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits) (PDF Version - 456 K) Guidance Document Date adopted: 2017/12/13 Effective date: 2017/12/13 Foreword Guidance documents are meant to provide assistance to industry and health care…","rawSnapshotUrl":"/api/snapshots/raw/482327","browseUrl":"https://replay.healtharchive.ca/job-6/20260106185254/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/drug-identification-numbers-schedulec.html?wbdisable=true#ha_snapshot=482327","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}